Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mirati Therapeutics Inc (NASDAQ:MRTX)

5.58
Delayed Data
As of Jul 01
 +0.12 / +2.20%
Today’s Change
5.31
Today|||52-Week Range
52.00
-82.34%
Year-to-Date
No recent news for Mirati Therapeutics Inc.

Today’s Trading

Previous close5.46
Today’s open5.47
Day’s range5.42 - 5.65
Volume299,565
Average volume (3 months)326,483
Market cap$108.7M
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-17.90%
Earnings growth (this year)-19.18%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...-0.16-1.92%
PRQRProQR Therapeutics N...-0.01-0.21%
CRMECardiome Pharma Corp+0.35+6.84%
AQXPAquinox Pharmaceutic...+0.77+11.63%
Data as of 4:00pm ET, 07/01/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$1.15
Annual revenue (last year)$0.00
Annual profit (last year)-$64.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
Chief Operations Officer &
Executive VP
Mark J. Gergen
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs